Strides Pharma Science Ltd (BOM:532531)
ā‚¹ 1634.5 39.35 (2.47%) Market Cap: 150.72 Bil Enterprise Value: 170.45 Bil PE Ratio: 64.92 PB Ratio: 6.62 GF Score: 68/100

Strides Pharma Science Ltd to Consider to Combine CDMO Interests Call Transcript

Sep 25, 2023 / 11:30AM GMT
Release Date Price: ā‚¹535.65 (+7.42%)
Operator

Ladies and gentlemen, good day, and welcome to Strides Pharma Science Limited Investor Conference Call. (Operator Instructions) Please note that this conference is being recorded.

I now hand the conference over to Abhishek. Thank you, and over to you, sir.

Abhishek Singhal

A very good evening, and thank you for joining us today for Strides' Investor Call. Today, we have with us, Arun, Founder, Executive Chairperson and Managing Director; Badree, Executive Director Finance & Group CFO; and Neeraj Sharma, CEO Designate for OneSource.

Please note that today's discussion may be forward-looking in nature and must be viewed in relation to the risks pertaining to our business. After the end of this call, in case you have any further questions, please feel free to reach out to the Investor Relations team.

I now hand over this call to Arun to make the opening comments.

Arun Kumar Pillai
Strides Pharma Science Limited - Founder, Executive Chairperson & MD

Thank you, Abhishek, and thank you,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investorsā€™ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot